Market Value1,083,865,778
Total Holdings91
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CRL / Charles River Laboratories International, Inc.
XLO / Xilio Therapeutics, Inc.
LLY / Eli Lilly and Company
BMRN / BioMarin Pharmaceutical Inc.
AXSM / Axsome Therapeutics, Inc.
BHC / Bausch Health Companies Inc.
TWST / Twist Bioscience Corporation
TMCI / Treace Medical Concepts, Inc.
CCCC / C4 Therapeutics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
PHVS / Pharvaris N.V.
INBX / Inhibrx Biosciences, Inc.
RCEL / AVITA Medical, Inc.
KRYS / Krystal Biotech, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
NSPR / InspireMD, Inc.
VSTM / Verastem, Inc.
NPCE / NeuroPace, Inc.
THTX / Theratechnologies Inc.
EOLS / Evolus, Inc.
IOVA / Iovance Biotherapeutics, Inc.
HUM / Humana Inc.
LQDA / Liquidia Corporation
AXGN / Axogen, Inc.
PRAX / Praxis Precision Medicines, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
ACLX / Arcellx, Inc.
EPIX / ESSA Pharma Inc.
NRIX / Nurix Therapeutics, Inc.
INSP / Inspire Medical Systems, Inc.
IMUX / Immunic, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ORGO / Organogenesis Holdings Inc.
CELC / Celcuity Inc.
DSGN / Design Therapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
TARS / Tarsus Pharmaceuticals, Inc.
BCAB / BioAtla, Inc.
MRUS / Merus N.V.
NVCR / NovoCure Limited
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
SNN / Smith & Nephew plc - Depositary Receipt (Common Stock)
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
CVS / CVS Health Corporation
ANNX / Annexon, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SRDX / Surmodics, Inc.
TNGX / Tango Therapeutics, Inc.
AADI / Aadi Bioscience, Inc.
CSTL / Castle Biosciences, Inc.
ATRC / AtriCure, Inc.
NUVL / Nuvalent, Inc.
ALKS / Alkermes plc
GLTO / Galecto, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
BLFS / BioLife Solutions, Inc.
ETNB / 89bio, Inc.
BHVN / Biohaven Ltd.
AVDL / Avadel Pharmaceuticals plc
UTHR / United Therapeutics Corporation
URGN / UroGen Pharma Ltd.
KROS / Keros Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
GSK / GSK plc - Depositary Receipt (Common Stock)
VKTX / Viking Therapeutics, Inc.
XERS / Xeris Biopharma Holdings, Inc.
APLT / Applied Therapeutics, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
SLNO / Soleno Therapeutics, Inc.
RYZB / RayzeBio, Inc.
EXAS / Exact Sciences Corporation
KRTX / Karuna Therapeutics, Inc.
/ JASPER THERAPEUTICS INC
SPRY / ARS Pharmaceuticals, Inc.
INDV / Indivior PLC
TMDX / TransMedics Group, Inc.
VCEL / Vericel Corporation
ADVM / Adverum Biotechnologies, Inc.
BDTX / Black Diamond Therapeutics, Inc.
LUNG / Pulmonx Corporation
DICE / DICE Therapeutics Inc
ACRS / Aclaris Therapeutics, Inc.
STRO / Sutro Biopharma, Inc.
DXCM / DexCom, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
CRSP / CRISPR Therapeutics AG
MLYS / Mineralys Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc.
ANGO / AngioDynamics, Inc.
MORF / Morphic Holding, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
RYTM / Rhythm Pharmaceuticals, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
PLRX / Pliant Therapeutics, Inc.
SGEN / Seagen Inc
VRDN / Viridian Therapeutics, Inc.
ILMN / Illumina, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
TVTX / Travere Therapeutics, Inc.
FNA / Paragon 28, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
/ VENTYX BIOSCIENCES INC
NTRA / Natera, Inc.
INSM / Insmed Incorporated
FDMT / 4D Molecular Therapeutics, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
PODD / Insulet Corporation
SKIN / The Beauty Health Company
MCRB / Seres Therapeutics, Inc.
SIBN / SI-BONE, Inc.
ALPN / Alpine Immune Sciences, Inc.
DCTH / Delcath Systems, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
APGE / Apogee Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.
WGS / GeneDx Holdings Corp.
PCVX / Vaxcyte, Inc.
XENE / Xenon Pharmaceuticals Inc.
LYRA / Lyra Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
IRMD / IRADIMED CORPORATION
IMVT / Immunovant, Inc.